Navigation Links
Imprimis Pharmaceuticals Inc. Announces Shift in Strategic Direction
Date:11/6/2013

SAN DIEGO, Nov. 6, 2013 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company focused on commercializing novel drug formulations invented by physicians and pharmacists through their clinical experience with patients, today announced a shift in the focus of its strategic direction, aimed at diversifying its development and commercialization activities and shortening time to market. 

Under a strategic plan adopted by Imprimis on Friday, Imprimis plans to develop and commercialize its proprietary formulations in the ophthalmic, wound management, urology and pain therapeutic areas utilizing multiple commercialization pathways, including the FDA's Section 505(b)(2) pathway, and, uniquely, by selectively out-licensing its novel formulations to accredited pharmacies in order to satisfy physician and patient interest in Imprimis' drug assets.  For Imprimis' non-drug assets, such as drug-delivery vehicles, Imprimis will seek partnerships with wholesalers in order to make these technologies available to pharmacies across North America.

"We believe this is truly a new dawn for Imprimis," said Mark L. Baum, the company's Chief Executive Officer. "We are a company that believes that meaningful pharmaceutical innovation comes from the clinical interaction between one physician and one pharmacist in order to serve a patient's need.  In many cases, innovation generated from this interaction can create new drug development and commercialization opportunities that may serve much broader patient populations.  In such cases, through our strong relationship with a growing number of innovative physicians, pharmacists and research institutions, Imprimis will subject these formulations to our rigorous, proprietary evaluation process, seek to acquire ownership
'/>"/>

SOURCE Imprimis Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... IRVINE, Calif. , July 30, 2015 Edwards ... the science of heart valves and hemodynamic monitoring, today announced ... company,s Board of Directors. "Bob is an ardent ... been a true privilege to have him on Edwards, board ... A. Mussallem , Edwards, chairman and CEO.  "Bob has provided ...
(Date:7/30/2015)... International Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased 3% ... sales decreased 4% as currency reduced sales growth by ... diluted share as reported (EPS) were $2.73, compared with ... , an increase of 9% over the prior-year ...
(Date:7/30/2015)... , July 30, 2015  ResMed ... has signed a definitive agreement to acquire ... non-invasive ventilation and sleep-disordered breathing medical devices ... innovation and market reputation in China, combined with ResMed,s global leadership in sleep ... in China suffering ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... NEW YORK, Nov. 28, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0692953/Pharmaceutical-Packaging-Industry---2011-Yearbook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Packaging ... Summary ...
... 28, 2011  Inspiration Biopharmaceuticals, Inc. (Inspiration) today ... second of two pivotal studies in the Company,s ... initiated clinical study, OBI-1, an intravenous recombinant porcine ... the treatment of individuals with congenital hemophilia A ...
Cached Medicine Technology:Pharmaceutical Packaging Industry - 2011 Yearbook 2Pharmaceutical Packaging Industry - 2011 Yearbook 3Pharmaceutical Packaging Industry - 2011 Yearbook 4Pharmaceutical Packaging Industry - 2011 Yearbook 5Pharmaceutical Packaging Industry - 2011 Yearbook 6Pharmaceutical Packaging Industry - 2011 Yearbook 7Pharmaceutical Packaging Industry - 2011 Yearbook 8Pharmaceutical Packaging Industry - 2011 Yearbook 9Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1 2Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1 3Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1 4Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1 5
(Date:7/30/2015)... ... July 30, 2015 , ... OSF Healthcare System has been ... Most Wired Survey conducted by Hospitals & Health Networks. This marks the fourth consecutive ... by The Sisters of the Third Order of St. Francis . , Health ...
(Date:7/30/2015)... ... 30, 2015 , ... The connection between a healthy head of hair and a feeling of ... full head of hair can have a devastating impact on the daily life of a ... work place, the consequences of hair loss are not to be taken lightly. , The ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zaca Life has created ... With no water needed, the refreshing berry-flavored tablets are the perfect travel companion. ... natural ingredients that may help with body detoxification, protection and hydration,” said Mark ...
(Date:7/30/2015)... ... 30, 2015 , ... Eyepartner is proud to highlight that ... California’s Gaslamp Quarter Plaza for five years this September. , The surveillance ... for any suspicious activity. These cameras are in place to provide inarguable proof ...
(Date:7/30/2015)... ... 2015 , ... The American Telemedicine Association (ATA) is seeking ... exclusively on telemedicine, telehealth and mHealth. The meeting, expected to attract over 6,000 ... May 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting attracts the world’s ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3Health News:New Study Shows the Link between Hair Restoration and Healthy Self-Image 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3
... Reporter , WEDNESDAY, Feb. 15 (HealthDay News) -- Researchers report ... kicking off puberty in humans, a finding that offers insight ... who suffer from a rare disease that prevents the start ... family whose members have suffered from the disease confirmed that ...
... , WEDNESDAY, Feb. 15 (HealthDay News) -- ... or stroke, peripheral artery disease is often unrecognized and ... scientific statement released Wednesday. Peripheral artery disease is ... and other materials in the blood vessels outside the ...
... California reported the largest decline in drunk-driving deaths of any ... and a $232,000 grant from the California Office of Traffic ... to UC Irvine,s Health Education Center is helping to keep ... College DUI Awareness Program, UCI has organized nine universities into ...
... -- Hospitalization for underage drinking is common in the United ... estimated total cost for these hospitalizations is about $755 million ... also found geographic and demographic differences in the incidence of ... the Journal of Adolescent Health . Of ...
... potential for making medical isotopes with X-rays from a particle ... to the large scale. The Canadian Isotope Project, led by ... Research Council of Canada, and medical researchers in Winnipeg, Ottawa ... production levels with the delivery of a new particle accelerator ...
... TAMPA, Fla. A recent study conducted by researchers at ... in Rochester, Minn., has found that female cancer survivors receiving ... screening and who had never had cancer. The study ... Journal of Clinical Oncology . Researchers surveyed 19,948 women ...
Cached Medicine News:Health News:Gene Linked to Start of Puberty 2Health News:Circulatory Disorder Not Studied Enough in Women, Experts Say 2Health News:UCI leads multicampus collaboration to reward use of designated drivers 2Health News:Mayo Clinic: Hospitalization of US underage drinkers common, costs $755 million a year 2Health News:Canadian Isotope Project enters final stretch 2Health News:Female cancer survivors have 'worse health behaviors' than women with no cancer history 2
Inquire...
These claw forceps are single-action with sturdy teeth that provide a broad grasping area to hold the gallbladder securely during removal....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: